Key result
Uric acid prevents clinical disease and CNS inflammation in rats infected with Borna disease virus.
Why the study?
The physiological contribution of peroxynitrite (ONOO(-)) to the CNS inflammatory response against neurotropic virus infection was unclear.
Does uric acid administration prevent CNS inflammation and clinical disease in adult rats acutely infected with Borna disease virus?
Does uric acid administration prevent CNS inflammation and clinical disease in adult rats acutely infected with Borna disease virus?
Uric acid administration prevents CNS inflammation and blood-brain barrier permeability in BDV-infected rats, indicating that the neuroimmune response is dependent on peroxynitrite activity.
May implicate peroxynitrite in BDV neuroinflammation; hypothesis-generating in animal models only.
We have recently demonstrated that increased blood-CNS barrier permeability and CNS inflammation in a conventional mouse model of experimental allergic encephalomyelitis are dependent upon the production of peroxynitrite (ONOO(-)), a product of the free radicals NO* and superoxide (O2*(-)). To determine whether this is a reflection of the physiological contribution of ONOO(-) to an immune response against a neurotropic pathogen, we have assessed the effects on adult rats acutely infected with Borna disease virus (BDV) of administration of uric acid (UA), an inhibitor of select chemical reactions associated with ONOO(-). The pathogenesis of acute Borna disease in immunocompetent adult rats results from the immune response to the neurotropic BDV, rather than the direct effects of BDV infection of neurons. An important stage in the BDV-specific neuroimmune response is the invasion of inflammatory cells into the CNS. UA treatment inhibited the onset of clinical disease, and prevented the elevated blood-brain barrier permeability as well as CNS inflammation seen in control-treated BDV-infected rats. The replication and spread of BDV in the CNS were unchanged by the administration of UA, and only minimal effects on the immune response to BDV Ags were observed. These results indicate that the CNS inflammatory response to neurotropic virus infection is likely to be dependent upon the activity of ONOO(-) or its products on the blood-brain barrier.
No takes yet. Share an insight, caveat, or question.
Hooper et al. (2001) studied Borna disease virus (BDV) infection. Uric acid (UA) vs. Control treatment was evaluated on Onset of clinical disease, blood-brain barrier permeability, and CNS inflammation. Uric acid administration in adult rats acutely infected with Borna disease virus inhibited the onset of clinical disease and prevented elevated blood-brain barrier permeability and CNS inflammation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: